Predicting population coverage of T-cell epitope-based diagnostics and vaccines.
BACKGROUND
T cells recognize a complex between a specific major histocompatibility complex (MHC) molecule and a particular pathogen-derived epitope. A given epitope will elicit a response only in individuals that express an MHC molecule capable of binding that particular epitope. MHC molecules are extremely polymorphic and over a thousand different human MHC (HLA) alleles are known. A disproportionate amount of MHC polymorphism occurs in positions constituting the peptide-binding region, and as a result, MHC molecules exhibit a widely varying binding specificity. In the design of peptide-based vaccines and diagnostics, the issue of population coverage in relation to MHC polymorphism is further complicated by the fact that different HLA types are expressed at dramatically different frequencies in different ethnicities. Thus, without careful consideration, a vaccine or diagnostic with ethnically biased population coverage could result.


RESULTS
To address this issue, an algorithm was developed to calculate, on the basis of HLA genotypic frequencies, the fraction of individuals expected to respond to a given epitope set, diagnostic or vaccine. The population coverage estimates are based on MHC binding and/or T cell restriction data, although the tool can be utilized in a more general fashion. The algorithm was implemented as a web-application available at http://epitope.liai.org:8080/tools/population.


CONCLUSIONS
We have developed a web-based tool to predict population coverage of T-cell epitope-based diagnostics and vaccines based on MHC binding and/or T cell restriction data. Accordingly, epitope-based vaccines or diagnostics can be designed to maximize population coverage, while minimizing complexity (that is, the number of different epitopes included in the diagnostic or vaccine), and also minimizing the variability of coverage obtained or projected in different ethnic groups.
Bui
Huynh-Hoa
HH
La Jolla Institute for Allergy and Immunology, Division of Vaccine Discovery, 3030 Bunker Hill Street, Suite 326, San Diego, CA 92109, USA. hbui@liai.org
Sidney
John
J
Dinh
Kenny
K
Southwood
Scott
S
Newman
Mark J
MJ
Sette
Alessandro
A
D000465:Algorithms; D018604:Epitope Mapping / Q000379:methods*; D018984:Epitopes, T-Lymphocyte / Q000235:genetics* / Q000276:immunology*; D005787:Gene Frequency; D005828:Genetics, Population; D005838:Genotype; D006680:HLA Antigens / Q000235:genetics* / Q000276:immunology*; D006801:Humans; D007118:Immunoassay / Q000379:methods; D012984:Software; D013601:T-Lymphocytes; D014612:Vaccines / Q000276:immunology*
D018984:Epitopes, T-Lymphocyte; D006680:HLA Antigens; D014612:Vaccines